FDA under pressure to relax drug rules
Abstract
Industry says antibiotic pipeline is being blocked by overly stringent clinical-trial requirements for new treatments.
- Publication:
-
Nature
- Pub Date:
- December 2012
- DOI:
- 10.1038/492019a
- Bibcode:
- 2012Natur.492...19L